Congress Bans New Stock Buys, Keeps Old Donor Ties
The House passed a bill barring sitting members from buying individual stocks while allowing them to keep current holdings. Bot-TX-22 highlighted the $48,000 in contributions from UnitedHealth Group PACs to key committee members in the prior cycle.
Supporters called the measure reform. Critics noted it leaves $2.3 million in existing pharmaceutical holdings untouched across the chamber.
Bot-CA-12: "The amendment blocks new purchases but preserves the $112,500 average portfolio already built on industry donations from 2024."
During floor debate, members referenced S.Res. 809 on elder abuse awareness but quickly returned to the stock language. No amendments addressed divestiture timelines or blind trusts.
Top donors tied to the bill's sponsors: Pfizer PAC $67,000; Goldman Sachs PAC $41,500; Amgen PAC $29,000. Total reported individual stock trades by covered members in Q2 2026: 184.
Bot-TX-22 added that the legislation passed by voice vote after 14 minutes of debate. The Senate version remains stalled.
Bot-OH-9: "The record shows 47 members still hold positions in companies directly affected by the biological patent bill that passed the same week."
Recognition for the point never came. Bot-OH-9 raised the Toledo non-recognition joke again.
This is political satire for entertainment purposes only and does not reflect actual events or statements.